These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Design of a potent combined pseudopeptide endothelin-A/endothelin-B receptor antagonist, Ac-DBhg16-Leu-Asp-Ile-[NMe]Ile-Trp21 (PD 156252): examination of its pharmacokinetic and spectral properties. Cody WL, He JX, Reily MD, Haleen SJ, Walker DM, Reyner EL, Stewart BH, Doherty AM. J Med Chem; 1997 Jul 04; 40(14):2228-40. PubMed ID: 9216842 [Abstract] [Full Text] [Related]
3. A structure-activity study of a C-terminal endothelin analogue. Cassano E, Galoppini C, Giusti L, Hamdan M, Macchia M, Mazzoni MR, Menchini E, Pegoraro S, Rovero P. Folia Biol (Praha); 1998 Jul 04; 44(1):11-4. PubMed ID: 10730869 [Abstract] [Full Text] [Related]
4. An endothelin B receptor-selective antagonist: IRL 1038, [Cys11-Cys15]-endothelin-1(11-21). Urade Y, Fujitani Y, Oda K, Watakabe T, Umemura I, Takai M, Okada T, Sakata K, Karaki H. FEBS Lett; 1992 Oct 12; 311(1):12-6. PubMed ID: 1397285 [Abstract] [Full Text] [Related]
5. Truncated analogues of endothelin and sarafotoxin are selective for the ETB receptor subtype. Heyl DL, Cody WL, He JX, Flynn MA, Welch KM, Reynolds EE, Doherty AM. Pept Res; 1993 Oct 12; 6(5):238-41. PubMed ID: 8257799 [Abstract] [Full Text] [Related]
6. Identification and characterization of type A endothelin receptors in MMQ cells. Wu-Wong JR, Chiou W, Magnuson SR, Witte DG, Lin CW. Mol Pharmacol; 1993 Aug 12; 44(2):285-91. PubMed ID: 8355666 [Abstract] [Full Text] [Related]
7. Endothelin-1-induced circulatory response in the rat: the role of ETA and ETB receptors. Szalay L, Boros M, Baranyi L, Okada H, Nagy S. Acta Chir Hung; 1997 Aug 12; 36(1-4):340-2. PubMed ID: 9408395 [Abstract] [Full Text] [Related]
8. Endothelin-1 induces mucosal mast cell degranulation and tissue injury via ETA receptors. Boros M, Szalay L, Kaszaki J. Clin Sci (Lond); 2002 Aug 12; 103 Suppl 48():31S-34S. PubMed ID: 12193049 [Abstract] [Full Text] [Related]
9. Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer. Nelson JB, Chan-Tack K, Hedican SP, Magnuson SR, Opgenorth TJ, Bova GS, Simons JW. Cancer Res; 1996 Feb 15; 56(4):663-8. PubMed ID: 8630991 [Abstract] [Full Text] [Related]
10. Toward the rational development of peptidomimetic analogs of the C-terminal endothelin hexapeptide: development of a theoretical model. Macchia M, Barontini S, Ceccarelli F, Galoppini C, Giusti L, Hamdan M, Lucacchini A, Martinelli A, Menchini E, Mazzoni MR, Revoltella RP, Romagnoli F, Rovero P. Farmaco; 1998 Feb 15; 53(8-9):545-56. PubMed ID: 10081817 [Abstract] [Full Text] [Related]
11. Monocyclic endothelins: examination of the importance of the individual disulfide rings. Cody WL, Doherty AM, He XQ, Rapundalo ST, Hingorani GP, Panek RL, Major TC. J Cardiovasc Pharmacol; 1991 Feb 15; 17 Suppl 7():S62-4. PubMed ID: 1725434 [Abstract] [Full Text] [Related]
12. The C-terminal hexapeptide, endothelin-(16-21), discriminates between different endothelin receptors. Maggi CA, Giuliani S, Patacchini R, Santicioli P, Rovero P, Giachetti A, Meli A. Eur J Pharmacol; 1989 Jul 04; 166(1):121-2. PubMed ID: 2553427 [No Abstract] [Full Text] [Related]
13. Design of a functional hexapeptide antagonist of endothelin. Cody WL, Doherty AM, He JX, DePue PL, Rapundalo ST, Hingorani GA, Major TC, Panek RL, Dudley DT, Haleen SJ. J Med Chem; 1992 Aug 21; 35(17):3301-3. PubMed ID: 1324321 [No Abstract] [Full Text] [Related]
15. Influence of cadmium ions on endothelin-1 binding and calcium signaling in rat glioma C6 cells. Koschel K, Meissner NN, Tas PW. Toxicol Lett; 1995 Nov 15; 81(2-3):189-95. PubMed ID: 8553374 [Abstract] [Full Text] [Related]
16. Synthesis and structure-activity relationship studies of new endothelin pseudopeptide analogues containing alkyl spacers. Galoppini C, Giusti L, Macchia M, Hamdan M, Mazzoni MR, Calvani F, Rovero P. Farmaco; 1999 Apr 30; 54(4):213-7. PubMed ID: 10384713 [Abstract] [Full Text] [Related]